XPH 250117 49.00C (XPH250117C49000) Stock Options, News & Quotes

0.13
0.000.00%

15min DelayClose Dec 30 16:00 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

SpyderCall

Mar 11 23:04

Is anybody riding this wave with me?

$Bristol-Myers Squibb (BMY.US)$
$Invesco Pharmaceuticals ETF (PJP.US)$ $Ishares Trust U.S. Pharmaceuticals Etf (IHE.US)$ $Spdr Series Trust Spdr S&P Pharmaceuticals Etf (XPH.US)$
$SPDR S&P Biotech ETF (XBI.US)$ $VanEck Biotech ETF (BBH.US)$

SpyderCall: It is starting to look like a double bottom on the weekly candles.

SpyderCall

Feb 28 19:11

It is starting to look like a double bottom on the weekly candles.

$Bristol-Myers Squibb (BMY.US)$
The price action of BMY is finding support near the 47.50 price point. It appears to be forming a double bottom on the charts so far.
There is a bullish divergence on several of the popular oscillating indicators for the weekly candles. The major indicators for the daily candles, like RSI and MACD, are all officially in bullish territory.
Ultimately, the price would need to climb out of the trading ...

SpyderCall

Nov 14, 2023 16:53

Is it Time to Start Picking the Low Hanging Fruit?

$Spdr Series Trust S&P Regional Bkg Etf (KRE.US)$
From Worst to First?
The worst performing sector year-to-date was the best performing sector today after the CPI data release. The regional banking sector was hit especially hard this year.
Smaller bank’s capital ratios came into question earlier this year when large outflows of deposits hit a few regional banks. This caused a banking scare and a big selloff in the bank related ETFs. Smaller, more...

Teach and Learn Together here!

BioPharm Insight US

Oct 10, 2022 07:49

Columns Weekly FDA Drug Pipeline Calendar (Oct 10- Oct 13)

Announcement Document
$AbbVie (ABBV.US)$: AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022
$Protagonist Therapeutics (PTGX.US)$: Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis
$PTC Therapeutics (PTCT.US)$: Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022
$Scholar Rock (SRRK.US)$: Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy
Follow for more insights and top news for pharmacy industry! $The Health Care Select Sector SPDR® Fund (XLV.US)$ $Spdr Series Trust Spdr S&P Pharmaceuticals Etf (XPH.US)$ $Ishares Trust U.S. Pharmaceuticals Etf (IHE.US)$